A Comprehensive Review of Thyroid Eye Disease Pathogenesis: From Immune Dysregulations to Novel Diagnostic and Therapeutic Approaches

被引:2
作者
Kulbay, Merve [1 ]
Tanya, Stuti M. [1 ]
Tuli, Nicolas [2 ]
Dahoud, Jade [3 ]
Dahoud, Andrea [1 ]
Alsaleh, Fares [1 ]
Arthurs, Bryan [1 ]
El-Hadad, Christian [1 ]
机构
[1] McGill Univ, Dept Ophthalmol & Visual Sci, Montreal, PQ H4A 0A4, Canada
[2] McGill Univ, Fac Med & Hlth Sci, Montreal, PQ H3G 2M1, Canada
[3] Univ Montreal, Fac Med, Montreal, PQ H3T 1J4, Canada
关键词
thyroid eye disease; grave's orbitopathy; grave's disease; grave's pathophysiology; deep learning for thyroid eye disease; immunotherapy for grave's disease; SEVERE GRAVES ORBITOPATHY; LIFE EXTENDED ANTIBODY; GROWTH-FACTOR-I; NEXT-GENERATION; IGF-1; RECEPTOR; ANTAGONIST ANTIBODY; OCULAR SURFACE; SINGLE-BLIND; RISK-FACTORS; DRY EYE;
D O I
10.3390/ijms252111628
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Thyroid eye disease is a complex inflammatory disorder of the orbit that has gained tremendous interest over the past years, and numerous scientific efforts have been deployed to elucidate its pathophysiology for novel drug development. Our manuscript will delve into the molecular dysregulations involved in the pathogenesis of thyroid eye disease that led to its clinical manifestations. Abnormalities within the apoptotic pathway, inflammatory cascade, and autoimmune regulatory systems will be covered. We will further discuss the challenges involved in its diagnosis and management and provide a summary of the current diagnostic tools (i.e., molecular biomarkers, diagnostic scores) from the perspective of clinicians. Finally, our comprehensive literature review will provide a thorough summary of most recent preclinical and clinical studies around the topic of thyroid eye disease, with an emphasis on the manuscripts published within the last five years. We believe our manuscript will bring novelty within the field by bridging the fundamental sciences with the clinical aspect of this disease. This review will be a great tool for clinicians in better understanding the pathogenesis of thyroid eye disease while providing an outlook on future perspectives (i.e., liquid biopsies, artificial intelligence).
引用
收藏
页数:32
相关论文
共 164 条
  • [1] Comparative proteomic analysis of tear fluid in Graves' disease with and without orbitopathy
    Aass, C.
    Norheim, I.
    Eriksen, E. F.
    Bornick, E. C.
    Thorsby, P. M.
    Pepaj, M.
    [J]. CLINICAL ENDOCRINOLOGY, 2016, 85 (05) : 805 - 812
  • [2] Agarwal AK, 2024, StatPearls
  • [3] Single-cell transcriptomics in thyroid eye disease
    Ahsanuddin, Sofia
    Wu, Albert Y.
    [J]. TAIWAN JOURNAL OF OPHTHALMOLOGY, 2024, 14 (04) : 554 - 564
  • [4] Akbar MA, 2020, J SOFTW-EVOL PROC, V32, DOI [10.1002/smr.2246, 10.1016/j.joco.2019.10.002]
  • [5] Comparison of intravenous methylprednisolone therapy vs. oral methylprednisolone therapy in patients with Graves' ophthalmopathy
    Aktaran, S.
    Akarsu, E.
    Erbagci, I.
    Araz, M.
    Okumus, S.
    Kartal, M.
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2007, 61 (01) : 45 - 51
  • [6] The Pro12Ala PPARγ gene polymorphism: possible modifier of the activity and severity of thyroid-associated orbitopathy (TAO)
    Alevizaki, Maria
    Mantzou, Emily
    Cimponeriu, Adriana
    Saltiki, Katerina
    Philippou, George
    Wiersinga, Wilmar
    [J]. CLINICAL ENDOCRINOLOGY, 2009, 70 (03) : 464 - 468
  • [7] Aoun T, 2024, Stresses, V4, P54, DOI [10.3390/stresses4010004, DOI 10.3390/STRESSES4010004]
  • [8] MECHANISMS OF DISEASE Graves' Ophthalmopathy
    Bahn, Rebecca S.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (08) : 726 - 738
  • [9] Tears as a Source of Biomarkers in the Diagnosis of Graves' Orbitopathy
    Bajkowska, Diana
    Szelachowska, Malgorzata
    Buczynska, Angelika
    Kretowski, Adam Jacek
    Siewko, Katarzyna
    [J]. BIOMOLECULES, 2022, 12 (11)
  • [10] Future Projections in Thyroid Eye Disease
    Barbesino, Giuseppe
    Salvi, Mario
    Freitag, Suzanne K.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2022, 107 : S47 - S56